Plain-English translation of NCT07113522 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a research study testing two experimental medications — and — to see if they can help people with moderate to severe inflammatory bowel disease (either Crohn's disease or ulcerative colitis). The study will look at how safe these medications are, how well they work, and how your body processes them. Researchers will compare the medications alone and also test one medication combined with standard care.
Current treatments don't work well enough for everyone with inflammatory bowel disease, and some people experience serious side effects. This trial is exploring whether these new medications could offer better relief from symptoms and inflammation with fewer complications.
You likely qualify if…
You likely don't qualify if…
Depending on which group you're assigned to, you'll either take tablets of the medication by mouth or receive intravenous infusions at the clinic, possibly combined with your current standard treatment. You'll have multiple visits to the clinic for safety checks, blood tests, and scans to see how the medication is working. The study will track how you feel, measure inflammation in your bowel through endoscopy, and monitor how your body handles the medication.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States